[1]Fu J, Wang H. Precision diagnosis and treatment of liver cancer in China[J]. Cancer Lett, 2018,412(1): 283-288.
[2]Kudo M. Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond[J]. World J Gastroenterol, 2019,25(7): 789-807.
[3]Deng XJ, Gong ShX, Yang ShH, et al. MicroRNA-539 inhibiting the occurrence and development of hepatocellular carcinoma by targeting E2F transcription factor 3[J]. Acta Anatomica Sinica, 2018, 49(4):469-474. (in Chinese)
邓学军, 龚邵新, 杨胜辉, 等. MicroRNA-539靶向调控E2F转录因子3抑制肝癌的发生与发展[J]. 解剖学报, 2018, 49(4):469-474.
[4]Ren S, Xin Z, Xu Y, et al. Construction and analysis of circular RNA molecular regulatory networks in liver cancer[J]. Cell Cycle, 2017,16(22): 2204-2211.
[5]Zhang X, Xu X, Ge G, et al. miR-498 inhibits the growth and metastasis of liver cancer by targeting ZEB2[J]. Oncol Rep, 2019,41(3): 1638-1648.
[6]Zhou XJ, Wang XF, Feng YJ, et al. xpressions of SMG-1, ATM and P53 in laryngeal squamous cell carcinoma and their clinical significance[J]. Journal of Southern Medical University, 2016,36(1): 50-55. (in Chinese)
周学军, 王晓凤, 冯勇军, 等. 喉鳞癌组织中SMG-1、ATM和P53的表达及临床意义[J]. 南方医科大学学报, 2016,36(1): 50-55.
[7]Han LL, Nan HC, Tian T, et al. Expression and significance of the novel tumor-suppressor gene SMG-1 in hepatocellular carcinoma[J]. Oncol Rep, 2014,31(6): 2569-2578.
[8]Lin X, Chen Y. Identification of potentially functional circRNA-miRNA-mRNA regulatory network in hepatocellular carcinoma by integrated microarray analysis[J]. Med Sci Monit Basic Res, 2018,24(1): 70-78.
[9]Xiong DD, Dang YW, Lin P, et al. A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma[J]. J Transl Med, 2018,16(1): 220-240.
[10]Yu J, Yang M, Zhou B, et al. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway[J]. Clin Sci, 2019,133(13): 1487-1503.
[11]Zhang PF, Wei CY, Huang XY, et al. Circular RNA circTRIM33-12 acts as the sponge of microRNA-191 to suppress hepatocellular carcinoma progression[J]. Mol Cancer, 2019,18(1): 105-119.
[12]Xing W, Zhou PC, Zhang HY, et al. Circular RNA circ_GLIS2 suppresses hepatocellular carcinoma growth and metastasis[J]. Liver Int, 2022, 42(3): 682-695.
[13]Wang H, Zhang Q, Cui W, et al. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway[J]. Cell Cycle, 2021, 20(20):2125-2136.
[14]Li J, Bao S, Wang L, et al. CircZKSCAN1 suppresses hepatocellular carcinoma tumorigenesis by regulating miR-873-5p/downregulation of deleted in liver cancer 1[J]. Dig Dis Sci, 2021, 66(12):4374-4383.
[15]Zhou H, Chen Y. CircRNA has_circ_0001806 promotes hepatocellular carcinoma progression via the miR-193a-5p/MMP16 pathway[J]. Braz J Med Biol Res, 2021, 54(12):e11459.
[16]Chen Z, Jin P, Chen Z, et al. The expression of circ_0090049 in hepatocellular carcinoma and the molecular regulation mechanism of other biological functions[J]. Anticancer Drugs, 2022, 33(1): 48-60.
[17]Lu H, Gao L, Lv J. Circ_0078710 promotes the development of liver cancer by upregulating TXNDC5 via miR-431-5p[J]. Ann Hepatol, 2021, 27(1):100551.
[18]Liu C, Zhang W, Xing W, et al. MicroRNA-498 disturbs the occurrence and aggression of colon cancer through targeting MDM2 to mediate PPARγ ubiquitination[J]. Life Sci, 2021, 277:119225-119233.
[19]Gao N, Wang FX, Wang G, et al. Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors[J]. Eur Rev Med Pharmacol Sci, 2018,22(6): 1693-1699.
[20]Zhao T, Chen Y, Sheng S, et al. Upregulating microRNA-498 inhibits gastric cancer proliferation invasion and chemoresistance through inverse interaction of Bmi1[J]. Cancer Gene Ther, 2019,26(11-12): 366-373.
[21]Li W, Jiang H. Up-regulation of miR-498 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting FOXO3[J]. Clin Res Hepatol Gastroenterol, 2020,44(1): 29-37.
[22]Yin DL, Lu PL, Yin RL, et al. Over-expression of PRRX1 induces apoptosis of hepatocellular carcinoma SMMC7721 cells through a p53-mediated mitochondrial apoptosis pathway[J]. Chinese Journal of Cancer Biotherapy, 2019,26(6): 662-668. (in Chinese)
尹东亮, 卢沛林, 尹润龙, 等. 过表达PRRX1 通过p53 介导的线粒体凋亡途径诱导肝癌SMMC7721 细胞凋亡[J]. 中国肿瘤生物治疗杂志, 2019,26(6): 662-668
[23]Gubanova E, Issaeva N, Gokturk C, et al. SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways[J]. Cell Cycle, 2013,12(24): 3770-3780.
|